Other languages Synlogic, Inc.

Equities

Delayed Nasdaq Other stock markets 01:30:00 2024-07-03 pm EDT			5-day change	1st Jan Change
1.46 ^USD	+2.10%		-3.95%	-62.08%

May. 14	Synlogic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 21	Synlogic, Inc. Announces Board Changes	CI

Synlogic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14
Synlogic, Inc. Announces Board Changes	Mar. 21
Synlogic, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19
Synlogic, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 19
Synlogic Board Approves Poison Pill Defense After Unsolicited Accumulation of Shares	Feb. 20
Synlogic Engages Ladenburg Thalmann & Co. Inc. to Assist in Strategic Review	Feb. 19
Cable Car Capital Discloses its Views on Synlogic	Feb. 16
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	Feb. 09
Sector Update: Health Care	Feb. 09
Synlogic Shares Fall After Move to Cease Operations, Cut Over 90% of Workforce	Feb. 09
Wall Street Set to Open Modestly Higher as S&P Hovers Just Above 5,000	Feb. 09
US Futures Nudge Higher as S&P Remains Just Above 5,000	Feb. 09
Top Premarket Decliners	Feb. 09
Synlogic, Inc. Announces Departure of Aoife Brennan as Chief Executive Officer	Feb. 08
Synlogic, Inc. Announces Decision to Discontinue Synpheny-3 Study	Feb. 08
Synlogic, Inc. Announces to Cease Operations	Feb. 08
Synlogic, Inc. Announces Departure of Aoife Brennan as President	Feb. 08
Synlogic to Evaluate Strategic Options	Feb. 07
Synlogic Says SYNB1353 Data Show Potential Treatment For Classical Homocystinuria	Feb. 02
Synlogic, Inc. Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria	Feb. 02

No results for this search